Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol(R) (amifostine), from AstraZeneca
Business Wire - Wed Aug 20, 1:07AM CDT
Clinigen Group plc ('Clinigen' or the 'Group'
Clinigen Group Acquires Oncology Support Therapy SAVENE(R) (dexrazoxane) from SpePharm AG
Business Wire - Mon Mar 31, 1:00AM CDT
Clinigen Group plc ('Clinigen' or the 'Group'
Clinigen Group plc: Half Year Results for the Six Months Ended 31 December 2013
Business Wire - Wed Feb 26, 1:18AM CST
Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its half year results for the six months ended 31 December 2013.